News

Ibn Sina posts 33% EPS growth in 9-month despite Q3 dip
23 Apr 2026
Source: The Business Standard

Ibn Sina Pharmaceutical Industry PLC reported a strong growth in earnings for the first nine months of the current fiscal year, despite a decline in its third-quarter performance.

According to its price-sensitive information, the company's consolidated earnings per share (EPS) rose to Tk19.94 during the July-March period, marking a 32.75% increase compared to the same period in the previous fiscal year.

The company's board approved the third-quarter financial statements at a meeting held today (22 April) in line with listing regulations. The financials are yet to be audited.

However, in the third quarter alone (January-March), the company's EPS declined by 16% to Tk4.67, down from Tk5.55 recorded in the corresponding period a year earlier.

Meanwhile, the company's consolidated net asset value (NAV) increased to Tk434.61 crore, up from Tk392.69 crore in the previous period.

 
About Us

At LankaBangla Securities PLC., we specialize in developing the country's most efficient stock brokerage workforce with unmatched skills and consummate perfectionism. Also, whichever corner of Bangladesh you are in, we have got you covered as you can find our branches and booths spread in the leading cities and towns countrywide.

Market
LBSL Logo
Important Links
HAVE A QUESTION?
© 2019 Copyright: LankaBangla Information System Terms and Conditions